TRT denied for missing prior authorization by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for trt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Requires Prior Authorization for Testosterone Replacement Therapy — and How to Appeal

Testosterone replacement therapy (TRT) is subject to prior authorization (PA) requirements by UnitedHealthcare, meaning the prescriber must submit clinical documentation for review and receive approval before the plan will cover the prescription. PA denials occur when the required request was not submitted before the prescription was filled, or when it was submitted but the documentation provided did not satisfy UHC's coverage criteria.

### Why This Denial Is Appealable

If a PA request was submitted and denied, the denial is a clinical determination subject to full appeal rights. The most common reason PA requests are denied is incomplete or insufficiently specific documentation — missing lab results, absent symptom documentation, or a brief request letter that does not map to the insurer's required criteria. A well-documented appeal that directly addresses every coverage criterion frequently reverses a PA denial. If the PA was never submitted (claim rejected at pharmacy), the prescriber can initiate a retroactive PA request or submit a new PA with complete documentation.

### Federal Appeal Framework

• Internal appeal: For a denied PA, file a written internal appeal with UHC. Standard decisions are required within 30 days; urgent/expedited decisions within 72 hours when delay poses risk to health or ability to function.
• External review (ACA §2719): After exhausting internal appeals, independent external review by an accredited IRO is available. The IRO applies evidence-based clinical standards.
• ERISA §503: Employer-plan members have full-and-fair review rights, including access to all criteria and clinical references used in the denial.
• Timeline: File external review within approximately four months of the final internal denial. Expedited review is available for urgent clinical situations.

### Concrete Appeal Steps

1. Obtain the PA denial letter and UHC's current published clinical coverage policy for TRT — these define every criterion the documentation must address. 2. With your prescriber, audit every criterion against the existing chart record. 3. Request that your prescriber supplement the chart with any missing documentation (lab results, symptom history, evaluation for secondary causes). 4. Have your prescriber submit a structured PA appeal letter that mirrors the policy criteria item by item. 5. If the internal appeal is denied, escalate to external review.

### Documentation to Gather

• Diagnosis confirmation: Lab results establishing the clinical basis for the diagnosis, timed as required by the FDA-approved prescribing label; prescriber chart notes.
• Symptom documentation: Prescriber notes describing clinical presentation, functional impact, and symptom duration.
• Prior treatment or evaluation history: Notes documenting any assessment for reversible causes and any prior treatments with dates and outcomes.
• Prescriber medical-necessity letter: A structured letter that quotes each UHC coverage criterion and responds with the specific chart fact satisfying it.
• FDA prescribing label: A copy of the current label from DailyMed as supporting reference for the approved indication.

### Criteria-Mapping Structure

Copy each PA criterion from UHC's clinical coverage policy and complete the table:

| UHC PA Criterion | Chart/Lab Evidence Satisfying It | |---|---| | [Copy each criterion verbatim from UHC policy] | [Specific lab value, chart note date, prescriber observation] |

The prescriber's appeal letter should mirror this table in prose form, making it easy for the reviewing clinician to confirm each criterion is met without hunting through attachments.